Trial finds risk, but no benefit, with blood thinner ...

Low-dose rivaroxaban failed to cut the high cardiovascular risk in this population in a large randomized trial, contrasting ...

One in two people globally, or approximately 850 million, are affected with Chronic Kidney Disease (CKD), which is a leading ...

The thresholds for kidney function currently used to diagnose chronic kidney disease (CKD) reflect a true increase in the ...

A moderately protein-restricted diet is tied to favorable kidney outcomes in patients with chronic kidney disease stage III ...

A series of major studies has shown that finerenone preserves kidney function, reduces cardiovascular risk, and improves ...

Finerenone reduced kidney function decline and cardiovascular-kidney events in non-diabetic CKD. Find out more from the ...

A series of major studies has shown that finerenone preserves kidney function, reduces cardiovascular risk, and improves survival across a much broader range of patients with chronic kidney disease ...

A new Lancet report warns chronic kidney disease is rising rapidly worldwide and could become the fifth leading cause of ...

Riello is a clinical pharmacy specialist focused on cardiorenalmetabolic disorders at Yale School of Medicine. Desai is a ...

Cats diagnosed with chronic kidney disease (CKD) may benefit from eating foods that contain less phosphorus, and lower ...